| #111 |
Faruk Halil Bursal |
Irobot |
2 |
| #111 |
Toby Freyman |
Boston Scientific Scimed |
2 |
| #111 |
Michael C. W. Coln |
— |
2 |
| #111 |
Ryan Sullenberger |
MIT |
2 |
| #111 |
Daniel Ron |
Amazon |
2 |
| #111 |
Yufang Xiao |
Merck |
2 |
| #111 |
Evan Charles Smith |
Recentive Analytics |
2 |
| #111 |
Evgueni Ivanov |
Analog Devices |
2 |
| #111 |
Hjalmar Edzer Ayco Huitema |
Creator Technology B.V. |
2 |
| #111 |
Joost J. Vlassak |
Harvard University |
2 |
| #111 |
Jean-Baptiste Frederic George Tristan |
Oracle |
2 |
| #111 |
Adam Weiss |
Ab Initio Technology |
2 |
| #111 |
Jaeyeon Kim |
Honeywell |
2 |
| #111 |
Anthony Nitti |
Novobiotic Pharmaceuticals |
2 |
| #111 |
Pachamuthu Kandasamy |
Alnylam Pharmaceuticals |
2 |
| #111 |
Ajit D'Souza |
Becton, Dickinson And |
2 |
| #111 |
Pavel Kamaev |
Avedro |
2 |
| #111 |
Michael C. Mountz |
Amazon |
2 |
| #111 |
Sirshendu Roopom Banerjee |
Bio-Rad Laboratories |
2 |
| #111 |
Vinay Raman |
Saudi Arabian Oil |
2 |
| #111 |
Siva Yegnanarayanan |
MIT |
2 |
| #111 |
Raj Nair |
Ericsson |
2 |
| #111 |
Kerren Kalai Swinger |
Ribon Therapeutics |
2 |
| #111 |
Brian D. Schultz |
RTX (Raytheon) |
2 |
| #111 |
Kenan Sahin |
Camx Power |
2 |
| #111 |
Guy L. Steele, Jr. |
Oracle |
2 |
| #111 |
Samuel V. Agresta |
Agios Pharmaceuticals |
2 |
| #111 |
Renen Bassik |
Covidien Lp |
2 |
| #111 |
Gregory V. Kryukov |
Ksq Therapeutics |
2 |
| #111 |
Sepehr Sadeghi |
Microsoft |
2 |
| #111 |
Samir Mitragotri |
University of California |
2 |
| #111 |
Elie Feirouz |
IBM |
2 |
| #111 |
Ajay Joseph |
Ibasis |
2 |
| #111 |
Michael Louis Wick |
Oracle |
2 |
| #111 |
Nanying Bian |
Emd Millipore |
2 |
| #111 |
Jeffrey W. Ruberti |
Northwestern University |
2 |
| #111 |
Xingkai Eric Chew |
Snap |
2 |
| #111 |
Patrick Haslett |
Shire Human Genetic Therapies |
2 |
| #111 |
Chris Casey |
Aescape |
2 |
| #111 |
William H. Cohn |
Worldpay |
2 |
| #111 |
Thomas Ryll |
Basf Se |
2 |
| #111 |
Yi-Hsun Chen |
Wistron |
2 |
| #111 |
Mikhail Kozlov |
Honeywell |
2 |
| #111 |
Pengcheng Zhou |
Voyager Therapeutics |
2 |
| #111 |
Scott Lundahl |
Dusa Pharmaceuticals |
2 |
| #111 |
Gary S. Muntz |
Cisco |
2 |
| #111 |
Sanjay Sarma |
MIT |
2 |
| #111 |
Jennifer A. Nelson |
Duracell U.S. Operations |
2 |
| #111 |
Noah Arliss |
Oracle |
2 |
| #111 |
Thomas Wai-Ho Lee |
Cyclerion Therapeutics |
2 |